True Green Bio Energy Share Price
192.00+2.85 (+1.51%)
+159.00% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
True Green Bio Energy Share Price
192.00+2.85 (+1.51%)
+159.00% past 1 Year
Technical meters

No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
True Green Bio Energy Share Price
192.00+2.85 (+1.51%)
+159.00% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly

No results found
Bulk & block deals

No results found
Insider trading & SAST

No results found
True Green Bio Energy Share Price
192.00+2.85 (+1.51%)
+159.00% past 1 Year
Corporate Actions
Date
Type
Details
Company details
True Green Bio Energy Share Price
192.00+2.85 (+1.51%)
+159.00% past 1 Year
Corporate filings & documents

No corporate filings & documents found
True Green Bio Energy Share Price
192.00+2.85 (+1.51%)
+159.00% past 1 Year
News
Marksans Reports Strong Q2 EBITDA Growth And Margin Expansion
Equity
MARKSANS
Centuryply reports strong second quarter revenue growth year on year
Equity
CENTURYPLY
Century Plyboards Reports Strong Second Quarter Consolidated Profit Growth
Equity
CENTURYPLY
Redtape Reports Stronger Second Quarter Consolidated Net Profit
Equity
REDTAPE
JTEKT India Reports Strong Second Quarter Revenue Growth
Equity
JTEKTINDIA
SMS Pharmaceuticals Reports Strong Q2 EBITDA Growth And Margin Expansion
Equity
SMSPHARMA
JTEKT India Reports Slight Year On Year Decline In Second Quarter Net Profit
Equity
JTEKTINDIA
Marksans Reports Strong Second Quarter Revenue Growth Year On Year
Equity
MARKSANS
Marksans Pharma reports strong second quarter consolidated profit growth
Equity
MARKSANS
Lal PathLabs Reports Stronger Q2 EBITDA And Improved Operating Margin
Equity
LALPATHLAB
Lal PathLabs Reports Strong Second Quarter Revenue Growth Year On Year
Equity
LALPATHLAB
Lal PathLabs Reports Strong Second Quarter Net Profit Growth
Equity
LALPATHLAB
SMS Pharmaceuticals Reports Strong Second Quarter Revenue And Profit Growth
Equity
SMSPHARMA
Arman Financial Services Reports Strong Second Quarter Revenue Growth
Equity
ARMANFIN
Arman Financial Services Reports Sharp Year On Year Profit Growth
Equity
ARMANFIN
NDR Auto Components Reports Higher Q2 EBITDA Despite Margin Compression
Equity
NDRAUTO
NDR Auto Components Reports Stronger Second Quarter Revenue And Profit
Equity
NDRAUTO
Exide Industries Reports Stronger Second Quarter EBITDA And Margin
Equity
EXIDEIND
Biocon Reports Q2 Revenue Growth To Rs 4400 Crores
Equity
BIOCON
Exide Industries Reports Strong Second Quarter Revenue Growth
Equity
EXIDEIND

